Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis

Published:2016-11 Issue:11 Volume:3 Page:e510-e520
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Kanters Steve,Vitoria Marco,Doherty Meg,Socias Maria Eugenia,Ford Nathan,Forrest Jamie I,Popoff Evan,Bansback Nick,Nsanzimana Sabin,Thorlund Kristian,Mills Edward J

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference151 articles.

1. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries;Braitstein;Lancet,2006

2. Prevention of HIV-1 infection with early antiretroviral therapy;Cohen;N Engl J Med,2011

3. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa;Tanser;Science,2013

4. Initiation of antiretroviral therapy in early asymptomatic HIV infection;N Engl J Med,2015

5. A trial of early antiretrovirals and isoniazid preventive therapy in Africa;N Engl J Med,2015

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing heterogeneity in treatment initiation guidelines in longitudinal randomized controlled trials;Journal of Statistical Planning and Inference;2025-03

2. Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study;Biomedicines;2024-09-12

3. Association between a lower T-CD4+/CD8+ lymphocyte ratio and cognitive impairment in older persons with HIV;2024-08-11

4. Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF versus elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trial;The Lancet Regional Health - Western Pacific;2024-08

5. Association of Integrase Strand Transfer Inhibitor-Based Antiretroviral Therapy With Blood Pressure and Sustained Hypertension in People With Human Immunodeficiency Virus;American Journal of Hypertension;2024-06-19